CERSCI THERAPEUTICS INC.

Profile

Company Names

CERSCI THERAPEUTICS INC.

Addresses

17217 WATERVIEW PARKWAY SUITE 1.202, DALLAS, TX 75252

Phone Numbers

2143066218

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$11,999,995.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-04-04 
$11,999,995.00 
$12,000,000.00 
$5.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TYLER 
 
BROUS 
DIRECTOR
SHATTUCK LABS, INC.   |  CERSCI THERAPEUTICS INC.   |  COLDQUANTA, INC.   |  LCP QUANTUM PARTNERS III, LLC   |  RESET TECHNOLOGY CORP   |  LCP QUANTUM PARTNERS IV, LLC   |  BBK VENTURES FUND I, LP   |  LCP QUANTUM PARTNERS V, LLC   |  KAYAK THERAPEUTICS, INC.   |  LCP QUANTUM PARTNERS VI, LLC
PAT 
 
CONFALONE 
DIRECTOR
CERSCI THERAPEUTICS INC.
SCOTT 
 
DAX 
DIRECTOR
CERSCI THERAPEUTICS INC.
BRENT 
 
DUNCAN 
DIRECTOR
CERSCI THERAPEUTICS INC.   |  DEEP BLUE MEDICAL ADVANCES, INC.
DAVID 
 
GENECOV 
DIRECTOR
FOREST PARK MEDICAL CENTER AT SOUTHLAKE, LLC   |  DIALECTIC THERAPEUTICS, INC.   |  CERSCI THERAPEUTICS INC.   |  CESSATION THERAPEUTICS, INC.
JOHN D. 
 
HARKEY, JR. 
DIRECTOR
CERSCI THERAPEUTICS INC.
DAVID 
 
HITT II 
DIRECTOR
CERSCI THERAPEUTICS INC.
PERRY 
 
MOLINOFF 
DIRECTOR
MELIOR PHARMACEUTICALS I, INC.   |  CYNAPSUS THERAPEUTICS INC.   |  CERSCI THERAPEUTICS INC.
DENNIS 
 
ROBBINS 
DIRECTOR
XW LLC   |  CERSCI THERAPEUTICS INC.
LUCAS 
 
RODRIGUEZ 
DIRECTOR, EXECUTIVE OFFICER
CERSCI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-20
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-04-04 
2019-10-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#